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1. Introduction 
Alpha-fetoprotem (a-FP), a protein of fetal orism 
which is absent in sera of normal adults, has been 
recognized also as a tumor antigen associated with 
hepatoma and with malignant teratoma [ 1 ]. The 
detection of ~,-FP, and its evaluation as a serological 
test for prtmaw liver cancer, have been attempted in 
several laboratories [2-4]. Recently, the development 
of a sensitive radioimmunoassay for a-FP has been 
reported [5]. One preret~uisite for an immunoassay of 
any sort is, of ¢ou'rse, a monospecifie antiserum which 
will not react with any other serum component. 
The methods generally employed for preparation 
of such a monospeciflc anti~.FP serum utilize whole 
fetal serum [6] -" serum from patients with hepato- 
cellular carcinor, m [7] for immumzatlon, and exhaus- 
tive adsorption of the resultant antiserum wRh normal 
human plasma. Thls method, however, uns the risk 
that some serum components from normal human 
plasma may contaminate th antiserum preparation. 
For this reason, in preliminary experiments in which 
we tried to use the above approach, we chc.se for 
adsorption human plasma that has been cross-linked 
by glutaraldehyde. Wedid not find this method for 
preparing anti-a-FP serum satisfaetot3", as the repeated 
adsorptions with msolubflized normal plasma caused a 
drastic decrease inthe anP ~.-FP titer. 
In a recent publication tS] it was reported that 
wfetoprotein of rat has a very strong estrogen.binding 
capacity, thus enabling specific autoradiograph auay 
for the protein using labeled estradlol or estrone, it
was, therefore, anticipated that the use of a prepara- 
tion in which estrwtiol is bound to an insoluble matrix 
may serve aA a means to adsorb wFP from fetal serum 
North~lollandl l~b~llk~ COr~l~ny - Am~,erdan, 
or from the sera of hepatoma paUents. We wish to 
report he preparation of such an insoluble cstradiot- 
containing adsorbent, the specific binding of ¢~-FP to 
it, and the use of the resulting material for preparation 
of monospecific anti-wFP serum. 
2o Materials and methods 
Sepharose 4B was obtained from Pharma¢ia, Uply 
sala; diaminononane from Fluka, Switzerland; labeled 
estradi'q (estradiob17~-[4-3I-I], 100 mCi/mM) was 
fi om New England Nuclear, Boston; estradiol. 17//- 
monoh.~misuccinate from Ikapharm, Israel; and 
1.ethyl-3-(3-diethytaminepropyl) carSodiimide (EDCI) 
from the Ott Chemtcals Company, l¢.u3kagon, 
l~hckdgan. 
Plasma samples contatmng a.FP from pauents w~th 
prunary liver earcmonfa were obtatr ~d through the 
caurtesy of Drs. Smith and Osunko)a from the Medical 
School of the Ibadan University in Ntgeria. Normal 
plasma was from the blood bank of the Kaplan Hospt- 
tal, Rehovot. Ant1 vt-FP ~erum samples were purchased 
from Instituto De lnvestlgacion, Ulta, Spain, or from 
Meloy Laboratories, Springfield, Virginia. 
2.1. Determination of e~:tradiol-binding proteins 
The estradiol binding proteins in plasma sampl/~s 
were determined bya radioassay using 14C-labeled 
estradiol, according to the method escribed by Lmdner 
et al. [91. 
2.2. Immunization procedures 
immuniztalon fa goat and two rabbits was pot: 
Jbrmed by multisite inUadermal injections of ~e 
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Sepharose-botmd ~-FP ,in complete Freund's adjuvant. 
0.5 g of Lhe insolubt,e material in a total volume of 
2 ram adjuvant mixture wa~ injected per goat or Fer 
rabb~t. A booster Laje,efion of a similar amount was 
given 10 days later. The aP'~amals were bled weekly, 
starting one w,eek afte,~ the booster injection. 
2.3_ Adsorpt~9~.s 
Whenever necessary, sera were a.dso~bed wi~h 5> 
aolubi~zcd human p]a~ma, obtained by polvm~fizatlon 
with glutar~ddehyde [10] (1 ml serum adsorbed w]flh 
with p~lymerized matefia~ ,obtained from I ~ plasma). 
2A.  Detection o f  *x-~P oz an~4-~-FP 
Imnaunod~ffus~on according to Ouchleflony I l l ]  
o~ immamoeaectrophoresis II2] were used for the 
deteclion of either a.FP or antibodies to it in the 
v.afious amples. 
3. Results 
3.!. Bindfng of estrad~ol ~,~ Sepharose 
The first stage ~n tb,e preparation of this material 
was ~he binding of diaminononane, viaone of its 
amino groups, to CNBr-acfivated 113] Sepharose. ~]n 
the second stage, ,estradiot-17~-monohemi~uce,~nate was 
bound Io the di~inonane-Sepharose preparation ,4a 
its carboxytie group, using a soluble carbodiimide 
reagent. 
To 10 g of activated Sepharose 4]3 2D mg of diamin,o- 
nonane were added in O. 1 M NaHCO 3. The reaction 
was ffllow,ed to proceed for 16 hr at 4 ~ 'with stirring, 
after wAich the maleriat was washed with O.l M 
NaI-tCO 3, foBowed by 5I~'~ dioxanie]watgr  so]ution. 
The esLradjo]- 17J3~ernisuccinate ,(9 rng) was activated 
in 50% d~oxm, ae/waIer s01u:t~n with EDC1 (5 ~g)  f~r 
30 rain at room temp. Afu,er centrifuging off the p~eci- 
pilate the m~teria] was added to the diaminononane- 
Sepharose. The reaction raixture was stirred for 1,6 hT 
at 4 ~. The amount of estradiol bound to diamino- 
nonane-Sepharose, 0.45 mg]l g Sephar,ose, was deter. 
mined by monitei-ing the optical density at 280 ~.,mn of 
the solution befol~ and a~,ter the bin ~ding procedure. 
3.2. Binding o f  a-~-~2 to eslracliol-Sepha~ose 
The various Nasma samNes {5 annl) were passed 
either oyez columns naad~,' with .estradiol-Sepharose - 
beads ,(2 g), or -- az a ,control - -  On .co!~larnns of  a 
Scp]aarose px~para~ion to which only diiLTnin,onane was 
attached. The arnoun~ of estraffio]-binding proteins in 
1hose samples before and afIer ,the ~d~olpfion was 
delermined by radioassay (table l). A.s seen from tla,e 
table, both normal and a-FP-containing phsma showed 
similar levels of estradi~-binding capacity. TIhis bind- 
ing capably was no1 decreased after passage through a 
column of flim-ainonm~e S phaTose. A drastic decrease 
was, however, observed afler pag~age ~f ~-FP-eontai#.- 
ing plasma ~hrough the estradSoi-Sepharose column. 
in tiffs ca~e ~he most efficient adsorption of es~radio~- 
bindhag pr,o~,eLr~ was obtained from f~acfions enr]che.d 
in ~-FP, obtained by precipitation between 40~ and 
70% saturn.ted ammonium sulp1~te. Only such 
preparations were used in subsequem experiments. 
No.~nal plasma, which does not eonta~ any ~-FP a~ 
tc~ed by Bnmunoflfffu~ion, ~aowed only &rdigh~ 
reduction ~n its estradiol-binding capacity after adsorp- 
tion on the estxadio] Sephazose column. The solu~Aons 
pas~d through ~he estradJo]-Sepha~ose column sti]] 
showed the presence of a.!~ in ~-nmunod~fusion ~n- 
d~ca~Lug tha~ the adsorption was not complete. 
A£ter passage of the samples containing ~-FP, 13he 
sfi~d~ol-gephmose columns were washed repeatedly 
wilh O. 15 M NaCI--O.01 M sodium phosphate buffer 
(PBS)~ pH 7.0, followed by ] M acetic acid. The acidic 
e]uate, though contai ruing protein (OD28 o = 1.35), dad 
n~t show the presence of a-FP. Washing with O.05 M 
arnmolaia, oi with 6 M urea, d~d not bring about ~he 
dufion of the ~-FP from the column. 
3.4. l ramuniza~ons 
Rabbits were irmnunized with the estra,dio2- 
Sepharo~e beads reacted with ~-FP enri~h,ed fractions 
and treated as described 'above. One rabbit (R- 1) was 
immunized wl,th the beads washed only with 9BS, 
whereas the s cond ~abbit .(R-2), .and one goat (G) 
were immunized with e beads obtained a~er washing 
with both PBS and aeefi,e ae~d. As shown in fig. 1, all 
three ar, imals ,developed an~tj-~-FP antibodies, but 
whereas in the antiserum toward the first rabbit (R-l) 
sever~ precipitin band.s in Jmmunodiffusion .could be 
.obsexved, ,thesera of e~ther 1t-2 or the .goat gave only 
two precipifin bands with a-FP ,containing plasma, of 
which one was ~denfieal with commerchl anfi-~-FP. 
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Table 1 
A~lso~pfio~ of est;adio]-binfling pxo~uins by 8cpha~os~ 
cs~ad~ol cohmm. 
Sample Binding of 14C-label~d estradi~l (%) 
Non- Aaron-bed Adsorbed 
ads~;t~d on ,$ami- on osl~a- 
non~a~ d~o~ 
Normal plasma 36 36 30 
Pla~ma of h,epa- 
~oraa pa'd~n~ 43 38 23 
f~a~on of ab~ 
p'la~a 40 38 17 
a-FP-~nfich~d* 
[rat-~io~ of 
plas~aa 46 40 2~ 
e-l~p-~mic]~od* 
f~ae5 an f~om 
aaon ~a~ plasma 39 35 33 
I]-]li17tlli1 ~ in l l l l  
~b~ miu 
(40 ,,~£/~) 2 20 20 
* Tl-e ~ac~on prec~pilat~fi ~ 70% sa't~:ralcd arnrnoni~ana 
.Tnth 4{)~ sa~a~c~l amino.urn su l fa te .  
Th( s~cond precip~fin band disappeared afte~ one 
adsorption of ~csc  anfise~a wilh "~anso]ubilizea %(ho~o 
human plasma (fig, 1). In contrast, ~ ~abbit in~aun~zed 
wilh ~hs whole s~rmn of  a hepatoma patient yielded 
anfis.~mm g~v~ng naany p~ecipi~a bands (fig. 2), wlfich 
we~e ,¢er~ difficult ~o elhn~ate ven by seve,x~] adsorp- 
tions w~da inso]ubilized hum~ p,]asma. Exhaus~ve 
ads~rpiion ~au~ed a .drastic decrease in ~he fi~e~ of 
an@~-FP (fig. 2). 
4. Discussion 
We haw described here a method by  w~hich a mona- 
~pedfic antiserum for ~-fetoprotein e~n be p~p~red. 
The me ,hhod i~ shnple, does not  ~quke  lxhe tedious 
p~h~lScafion of ~%_e anlSgen, ;and Not b~ng~ abo~/~ th~ 
formation of an~b~d~c~ ~o ~-I~P w~h~oh are con~xnin- 
a~ed by  antibodies ~gsitst o;dy one other ~e~na com. 
Fig. I. ~mmunod~ffu~ion on a~a~ phil. Middl~ we/]: p]asn~a of 
~cpa~on~a pafi~.L P~ph~a] we~]s: a) cornm~c:ml anti a-fc~o- 
~o~ein; ~) ~oat an~ser~re aga~s~ -fe~op;o~cin aft~z on~ 
adsorption %x,~h ~nso]ub',~iz~d h~man plasma; c) goat an~- 
s~ara b=fo~= adsor~dDn: ~) ,~abb~t (~-~3) sn~s~am Sg~ir~ 
¢~-fctop~o~ein, non adsorb=dr e) ~Dh)~t (~-2) snt~,~r~ a~ai~ 
~-fe~op~o~i~, ~on-adso;~d; f) ~abbi~ (R-2) alaZis~na SftO~ 
O~e ~flso~pfion ~h insoizbi~z~d human plasma. 
ponen~. The conlsaninafing antibodies can be essay 
removed in one adsorption step vzi~h ~soluS~1,iT.ed 
normal ph ma. 
2/-7~o raelhod en~ployed hexe is based on ~%e pr~a- 
cip]=s of  affnlity chron~atof~japhy - ~ lakes advantage 
of the affn~i~ b~nd~ng of ~s~radiol to t~-PP, an; ~ed 
an cstradio] column fez the l'pecific extlacfion of 01ds 
p/otei~ f~om whole scram. There ~e sew~al other 
plOlChas i~ lhe ~ m  ifl~ biadiug affi/ty Io est~sd]o] 
[]5] and they may aBo b'hud to ~he ~ol~rnn. However, 
a~ ~es~ pzo'feins with tho exception of one, a~e 
zcnlo¥cd f~o~ the c~urt~n By ac~,d elation. ~-FP w~s 
not ~ernoved fzom th~ bcad~ by i ,i_her I ~ accdc acid 
o~ 0.05 ~ a~-n~-_~o~ ox f~/~1 u~ea. Th~ may be due ~o 
t~e h~gh affmii"y b~nding of ~s~rad~o] ~o ~-F}L 73~ 
Icpo~[ed aJ~1~mi~y bi~d~ng constm~ of,t~-FP to estradio]- 
tenet m~ o~ flaese steroids to human ~mn a~bur~n is
1~ ,~I-'. ~15]. 
Tt~ nornm~ pl~nm ~en~ed t,o possess a lnm~ as 
]nuOt ea~[adiol-bhldirag'~ap~ci~ as Ihc t~-PP-enrich~d 
\ 
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The ,col,utah plOC~fluxe waz, ne"~erthe]e~ ~:sefa] as an 
cfficien/and d~le~£ n~v~nod fai ob~.~ning a ~nonos'peci- 
/ie anfi-~-FP antiseia, 
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FSg. 2. ~munodiffnsion ,~  agm" plats. Middle w~II: ~lasma of 
21epalo,~a pa!]¢nt. ~.'cfiph,e:r,,l welts; a) Iabbi~ -~.¢dsezmrn against 
~]aolc plasm~ of hepa~a~na patient. ~) The sane ~abbit a~li- 
~_~/uln afl,e~ lwo adsurpl~ons on insokbil~zefl ]ad~0an plasma. 
e) fahe ~%tisea'lam Yt¢~ th:rv= "Sd~o;plJons. d).C.£o~nna~zc~a] an~- 
fzaetions, even ~hough i, does no~ comain ~-FP, in: 
dicmtng lJa~ p.i~s~nce of  o,he; cvlrog~n-bJnding protvin~. 
Such es~rad~n]-17~blnd~ng ploteir~s wele m,oM plOb- 
ably p~esent in ihe a-FY-en~iehefl fla~i~ons as wel l  
They  ~ze  apparently e,~,~er eh~ted .from lh~v modified 
Setphamse by eludon wiIh acid, o~ did not lead 1o 
antibody formation, as - w i~ ~he exception o f  a smg]e 
pxo~m a~ mentioned above -- no olhe~ ma~badivs 
weze dete,ct.e~i in our ~xperhncntat ~-~serum that 
would ~eac~ with anofllvi human ~¢xmn protMn. 
~x-FP conld n,o~ [be eluled, lmdel the cond}t~ons 
used, ~om the est~adio]-Sepha~.ose cO]Ulnn, and it " 
thus seems that ~u,¢h a column may no~ by v,seful 
for the ~olalion of  a-FP by affirfity chromatography. 
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